Table 5.
Antimicrobial susceptibility* |
AMR genes and IS elements |
||||||||
---|---|---|---|---|---|---|---|---|---|
Strain |
Antimi-crobial |
Etest MIC (mg l− 1) |
Result |
Gene |
Upstream IS element |
Sequence† |
% ID |
% COV |
Associated resistance to drug class |
BFO17 |
MEM |
>32 |
R |
cfiA11 |
IS614B |
Chr |
100.00 |
99.20 |
Carbapenem |
IPM |
>32 |
R |
|||||||
MTZ |
>32 |
R |
nimJ |
IS614B |
Chr |
99.40 |
100.00 |
Nitroimidazole |
|
nimJ |
IS614B |
Chrc |
99.40 |
100.00 |
Nitroimidazole |
||||
CLI |
0.094 |
S |
|||||||
TZP |
>256 |
R |
|||||||
tetQ |
Chr |
99.34 |
99.34 |
Tetracycline |
|||||
cfxA4 |
Chr |
85.71 |
100.00 |
Cephamycin |
|||||
bexB |
Chrc |
91.21 |
100.00 |
Fluoroquinolone |
|||||
bexA |
Chr |
73.77 |
99.02 |
Fluoroquinolone |
|||||
BFO18 |
MEM |
>32 |
R |
cfiA2_1 |
ISBf12 |
Chr |
100.00 |
100.00 |
Carbapenem |
IPM |
16 |
R |
100.00 |
100.00 |
|||||
MTZ |
16 |
R |
nimD |
IS1169 |
S |
99.19 |
100.00 |
Nitroimidazole |
|
CLI |
6 |
R |
ermF‡ |
IS4351 |
Chrc |
99.83 |
72.03 |
Clindamycin |
|
ISBthe1‡ |
Chrc |
70.97 |
97.19 |
||||||
erm(F)§ |
Chrc |
99.58 |
29.71 |
||||||
lnu(AN2) |
Chrc |
100.00 |
100.00 |
Clindamycin |
|||||
TZP |
>256 |
R |
|||||||
ugd |
Chr |
65.69 |
53.04 |
Polymyxin |
|||||
bexA |
Chrc |
73.60 |
99.02 |
Fluoroquinolone |
|||||
bexB |
Chr |
91.14 |
100.00 |
Fluoroquinolone |
|||||
tet(Q) |
Chrc |
99.79 |
100.00 |
Tetracycline |
|||||
mef(En2) |
Chrc |
99.83 |
100.00 |
Macrolides |
|||||
S01 |
MEM |
>32 |
R |
cfiA13_1 |
IS1187 |
Chr |
99.20 |
100.00 |
Carbapenem |
IPM |
16 |
R |
|||||||
MTZ |
64 |
R |
nimE |
ISBf6 |
pBFS01_2 |
100.00 |
100.00 |
Nitroimidazole |
|
CLI |
>32 |
R |
erm(F) |
IS1187 |
Chr |
99.50 |
100.00 |
Clindamycin |
|
TZP |
6 |
S |
|||||||
tetQ |
Chr |
90.02 |
99.95 |
Tetracycline |
|||||
tet(Q) |
Chrc |
99.84 |
100.00 |
Tetracycline |
|||||
bexB |
Chrc |
91.06 |
100.00 |
Fluoroquinolone |
|||||
bexA |
Chr |
74.03 |
98.80 |
Fluoroquinolone |
|||||
BFO42 |
MEM |
0.094 |
S |
||||||
IPM |
0.25 |
S |
|||||||
MTZ |
8 |
R |
nimA |
ISBf13 |
pBFO32_1 |
98.64 |
96.61 |
Nitroimidazole |
|
CLI |
>256 |
R |
erm(F) |
IS613 |
Chr |
99.50 |
100.00 |
Clindamycin |
|
lnu(AN2) |
Chr |
100.00 |
100.00 |
Clindamycin |
|||||
TZP |
0.38 |
S |
|||||||
ugd |
Chr |
70.38 |
31.45 |
Polymyxin |
|||||
cepA-49 |
Chrc |
100.00 |
100.00 |
Cephalosporin |
|||||
mef(En2) |
Chr |
99.83 |
100.00 |
Macrolide |
|||||
ugd |
Chr |
71.15 |
31.11 |
Polymyxin |
|||||
tetQ |
Chrc |
100.00 |
100.00 |
Tetracycline |
|||||
bexB |
Chr |
99.12 |
100.00 |
Fluoroquinolone |
|||||
ere(D) |
Chr |
96.66 |
100.00 |
Erythromycin |
|||||
aadS |
Chrc |
99.88 |
100.00 |
Aminoglycoside |
|||||
OXA-347 |
IS613 |
Chrc |
100.00 |
100.00 |
Penicillin, cephalosporin |
||||
bexA |
Chr |
75.09 |
99.62 |
Fluoroquinolone |
|||||
BFO67 |
MEM |
8 |
R |
cfiA13_1 |
None |
Chr |
100.00 |
100.00 |
Carbapenem |
IPM |
0.5 |
S |
|||||||
MTZ |
0.19 |
S |
|||||||
CLI |
0.38 |
S |
|||||||
TZP |
2 |
S |
|||||||
cfxA2 |
ISBf11 |
Chr |
99.69 |
100.00 |
Cephamycin |
||||
mef(En2) |
Chr |
99.75 |
100.00 |
Macrolide |
|||||
lnu(AN2) |
Chr |
100.00 |
100.00 |
Clindamycin |
|||||
ugd |
Chrc |
66.76 |
56.30 |
Polymyxin |
|||||
tet(Q) |
Chr |
100.00 |
100.00 |
Tetracycline |
|||||
bexB |
Chrc |
90.92 |
100.00 |
Fluoroquinolone |
|||||
bexA |
Chr |
73.90 |
99.02 |
Fluoroquinolone |
|||||
BFO65 |
MEM |
32 |
R |
cfiA2_1 |
None |
Chr |
100.00 |
100.00 |
Carbapenem |
IPM |
1 |
S |
|||||||
MTZ |
0.25 |
S |
|||||||
CLI |
>256 |
R |
ermB |
Chrc |
99.19 |
98.66 |
Clindamycin |
||
TZP |
2 |
S |
|||||||
ugd |
Chr |
69.84 |
31.45 |
Polymyxin |
|||||
tetQ |
Chrc |
90.02 |
99.95 |
Tetracycline |
|||||
aadE |
Chrc |
100.00 |
100.00 |
Aminoglycoside |
|||||
aad9 |
Chrc |
100.00 |
100.00 |
Aminoglycoside |
|||||
bexB |
Chrc |
90.92 |
100.00 |
Fluoroquinolone |
|||||
bexA |
Chr |
73.53 |
99.02 |
Fluoroquinolone |
|||||
cfxA2 |
IS614 |
Chrc |
100.00 |
100.00 |
Cephamycin |
||||
tet(Q) |
Chrc |
99.84 |
100.00 |
Tetracycline |
Chr, Chromosome; MEM, meropenem; IPM, imipenem; MTZ, metronidazole; CLI, clindamycin; TZP, piperacillin/tazobactam.
*Results from previously published work following EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints [14].
†A subscript letter C denotes the complement strand.
‡A transposase has inserted itself, splitting the ermF gene in two.